Jamison Private Wealth Management, Inc. Gilead Sciences, Inc. Transaction History
Jamison Private Wealth Management, Inc.
- $657 Billion
- Q3 2024
A detailed history of Jamison Private Wealth Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 26,436 shares of GILD stock, worth $2.38 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
26,436
Previous 25,620
3.19%
Holding current value
$2.38 Million
Previous $1.76 Billion
26.09%
% of portfolio
0.34%
Previous 0.29%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
1,924Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.4 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.9 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.57 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.43 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $113B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...